352 related articles for article (PubMed ID: 22079344)
1. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance.
Moreb JS; Ucar D; Han S; Amory JK; Goldstein AS; Ostmark B; Chang LJ
Chem Biol Interact; 2012 Jan; 195(1):52-60. PubMed ID: 22079344
[TBL] [Abstract][Full Text] [Related]
2. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay.
Moreb JS; Zucali JR; Ostmark B; Benson NA
Cytometry B Clin Cytom; 2007 Jul; 72(4):281-9. PubMed ID: 17111384
[TBL] [Abstract][Full Text] [Related]
4. N,N-diethylaminobenzaldehyde (DEAB) as a substrate and mechanism-based inhibitor for human ALDH isoenzymes.
Morgan CA; Parajuli B; Buchman CD; Dria K; Hurley TD
Chem Biol Interact; 2015 Jun; 234():18-28. PubMed ID: 25512087
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.
Buchman CD; Hurley TD
J Med Chem; 2017 Mar; 60(6):2439-2455. PubMed ID: 28219011
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
[TBL] [Abstract][Full Text] [Related]
8. ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.
Kozovska Z; Patsalias A; Bajzik V; Durinikova E; Demkova L; Jargasova S; Smolkova B; Plava J; Kucerova L; Matuskova M
BMC Cancer; 2018 Jun; 18(1):656. PubMed ID: 29902974
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity.
Muramoto GG; Russell JL; Safi R; Salter AB; Himburg HA; Daher P; Meadows SK; Doan P; Storms RW; Chao NJ; McDonnell DP; Chute JP
Stem Cells; 2010 Mar; 28(3):523-34. PubMed ID: 20054864
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of recombinant human mitochondrial and cytosolic aldehyde dehydrogenases by two candidates for the active metabolites of disulfiram.
Lam JP; Mays DC; Lipsky JJ
Biochemistry; 1997 Nov; 36(44):13748-54. PubMed ID: 9354647
[TBL] [Abstract][Full Text] [Related]
11. Distinct expression patterns and roles of aldehyde dehydrogenases in normal oral mucosa keratinocytes: differential inhibitory effects of a pharmacological inhibitor and RNAi-mediated knockdown on cellular phenotype and epithelial morphology.
Kato H; Izumi K; Saito T; Ohnuki H; Terada M; Kawano Y; Nozawa-Inoue K; Saito C; Maeda T
Histochem Cell Biol; 2013 Jun; 139(6):847-62. PubMed ID: 23250514
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells.
Croker AK; Allan AL
Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590
[TBL] [Abstract][Full Text] [Related]
13. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells.
Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X
Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769
[TBL] [Abstract][Full Text] [Related]
14. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.
Parajuli B; Georgiadis TM; Fishel ML; Hurley TD
Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.
Buchman CD; Mahalingan KK; Hurley TD
Chem Biol Interact; 2015 Jun; 234():38-44. PubMed ID: 25641190
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide.
Moreb J; Schweder M; Suresh A; Zucali JR
Cancer Gene Ther; 1996; 3(1):24-30. PubMed ID: 8785707
[TBL] [Abstract][Full Text] [Related]
17. Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay.
Zhou L; Sheng D; Wang D; Ma W; Deng Q; Deng L; Liu S
Cell Biol Toxicol; 2019 Apr; 35(2):161-177. PubMed ID: 30220009
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase activity plays no functional role in stem cell-like properties in anaplastic thyroid cancer cell lines.
Shimamura M; Kurashige T; Mitsutake N; Nagayama Y
Endocrine; 2017 Mar; 55(3):934-943. PubMed ID: 28040834
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G
BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875
[TBL] [Abstract][Full Text] [Related]
20. Differential Functional Roles of ALDH1A1 and ALDH1A3 in Mediating Metastatic Behavior and Therapy Resistance of Human Breast Cancer Cells.
Croker AK; Rodriguez-Torres M; Xia Y; Pardhan S; Leong HS; Lewis JD; Allan AL
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
